Dutch biotech Kiadis Pharma appointed Ray Barlow as chief business officer. Barlow most recently led UK-based data-driven drug discovery company E-therapeutics as its CEO. His prior roles include serving at Amgen (NASDAQ: AMGN) as executive director of corporate development and at Crucell Vaccines, a Netherlands-based company that’s now a subsidiary of Johnson & Johnson (NASDAQ: JNJ).
Kiadis, a clinical-stage firm, is developing cell therapies based on natural killer cells to treat cancers.
Sponsored · Whitepaper
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson
From Our Editors · Special Report
Learn what's fueling San Diego's biotech investment and partnership opportunities
From Our Editors · Podcast
Learn what's fueling San Diego's biotech investment and partnership opportunities
